Guy Leverger

Summary

Country: France

Publications

  1. ncbi request reprint [A brief history of treatments for childhood acute lymphoblastic leukaemia]
    Guy Leverger
    Hématologie oncologie pédiatrique, Hopital Armand Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris, UPMC, Paris 6, UMR 5938, France
    Bull Acad Natl Med 193:1495-9; discussion 1499-500. 2009
  2. pmc Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study
    Virginie Gandemer
    Department of Pediatric Hematology, University Hospital of Rennes, Rennes, France
    BMC Cancer 9:14. 2009
  3. pmc Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia
    Benoit Brethon
    Unité de Pédiatrie à Orientation Hématologique, Hopital Saint Louis, Paris, France
    BMC Cancer 6:172. 2006
  4. ncbi request reprint [Needs' assessment and resources for pediatric palliative care]
    G Leverger
    Service d hématologie oncologie pédiatrique, Hopital d Enfants Armand Trousseau, 75012 Paris, France
    Arch Pediatr 13:621-3. 2006
  5. doi request reprint [Inherited thrombocytopenias]
    G Leverger
    Service d hématologie et d oncologie pédiatrique, centre de référence des pathologies plaquettaires CRPP, Hopital Armand Trousseau, UMR S938, Universite Pierre et Marie Curie Paris 6, 75012 Paris, France
    Arch Pediatr 17:1185-91. 2010
  6. doi request reprint [Echinocandins in children]
    G Leverger
    Service d hématologie oncologie pédiatrique, Hopital Armand Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris, France
    Arch Pediatr 18:S33-41. 2011
  7. doi request reprint Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome
    Paola Ballerini
    Laboratoire d Hematologie, Hopital A Trousseau, INSERM E0210
    Haematologica 93:1658-65. 2008
  8. ncbi request reprint [Paediatric specificity of antifungals use]
    Marie Dominique Tabone
    Service d hémato oncologie pédiatrique, Hopital Trousseau, Paris, France
    Therapie 61:243-8. 2006
  9. ncbi request reprint [New insights into acute lymphoblastic leukemia]
    Judith Landman-Parker
    Hématologie et Oncologie Pédiatrique, Hopital Armand Trousseau, 26 avenue du Dr A Netter, 75571 Paris Cedex 12
    Bull Acad Natl Med 193:1501-7. 2009
  10. ncbi request reprint [Towards cure for all children with acute lymphoblastic leukemia?]
    Andre Baruchel
    Hématologie Pédiatrique, Hopital Robert Debre, 48 Bld Serurier, 75019 Paris
    Bull Acad Natl Med 193:1509-17. 2009

Collaborators

Detail Information

Publications13

  1. ncbi request reprint [A brief history of treatments for childhood acute lymphoblastic leukaemia]
    Guy Leverger
    Hématologie oncologie pédiatrique, Hopital Armand Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris, UPMC, Paris 6, UMR 5938, France
    Bull Acad Natl Med 193:1495-9; discussion 1499-500. 2009
    ..As a result, the chance of cure increased gradually over the last three decades. In rich countries, the overall survival rate among children with acute lymphoblastic leukaemia now reaches 85 to 90%...
  2. pmc Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study
    Virginie Gandemer
    Department of Pediatric Hematology, University Hospital of Rennes, Rennes, France
    BMC Cancer 9:14. 2009
    ..Here we report the long-term results of the FRALLE 93 study conducted in the era before the use of tyrosine kinase inhibitors...
  3. pmc Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia
    Benoit Brethon
    Unité de Pédiatrie à Orientation Hématologique, Hopital Saint Louis, Paris, France
    BMC Cancer 6:172. 2006
    ..CD33 expression exceeded 20% in all cases...
  4. ncbi request reprint [Needs' assessment and resources for pediatric palliative care]
    G Leverger
    Service d hématologie oncologie pédiatrique, Hopital d Enfants Armand Trousseau, 75012 Paris, France
    Arch Pediatr 13:621-3. 2006
  5. doi request reprint [Inherited thrombocytopenias]
    G Leverger
    Service d hématologie et d oncologie pédiatrique, centre de référence des pathologies plaquettaires CRPP, Hopital Armand Trousseau, UMR S938, Universite Pierre et Marie Curie Paris 6, 75012 Paris, France
    Arch Pediatr 17:1185-91. 2010
    ..This paper describes the clinical and biological data, and current knowledge of the molecular findings of inherited thrombocytopenia, allowing a diagnostic approach to these diseases...
  6. doi request reprint [Echinocandins in children]
    G Leverger
    Service d hématologie oncologie pédiatrique, Hopital Armand Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris, France
    Arch Pediatr 18:S33-41. 2011
    ..Efficacy, safety, rare drugs interactions and specificity of action are advantages for therapy of invasive fungal infections. In France, micafungin and caspofungin are approved for a pediatric use...
  7. doi request reprint Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome
    Paola Ballerini
    Laboratoire d Hematologie, Hopital A Trousseau, INSERM E0210
    Haematologica 93:1658-65. 2008
    ..Likewise, the frequency and the prognostic significance in pediatric T-cell acute lymphoblastic leukemia of the newly characterized NUP214-ABL1 fusion transcript is not yet clear...
  8. ncbi request reprint [Paediatric specificity of antifungals use]
    Marie Dominique Tabone
    Service d hémato oncologie pédiatrique, Hopital Trousseau, Paris, France
    Therapie 61:243-8. 2006
    ..Relative interest and cost of available forms in the paediatric population in not always taken into account. For each different situation, an optimal strategy of antifungals use in children should be determined...
  9. ncbi request reprint [New insights into acute lymphoblastic leukemia]
    Judith Landman-Parker
    Hématologie et Oncologie Pédiatrique, Hopital Armand Trousseau, 26 avenue du Dr A Netter, 75571 Paris Cedex 12
    Bull Acad Natl Med 193:1501-7. 2009
    ..These advances point to new ways of targeting leukemic cells...
  10. ncbi request reprint [Towards cure for all children with acute lymphoblastic leukemia?]
    Andre Baruchel
    Hématologie Pédiatrique, Hopital Robert Debre, 48 Bld Serurier, 75019 Paris
    Bull Acad Natl Med 193:1509-17. 2009
    ..The current aims are to de-escalate treatment for better-defined low-risk groups, and to develop the use of new drugs and targeted therapies for high-risk groups, based on genome-wide analysis of the patient and the leukemic cell...
  11. ncbi request reprint Rituximab therapy for childhood Evans syndrome
    Brigitte Bader-Meunier
    Assistance Publique Hopitaux de Paris, Service d hématologie oncologie pédiatrique, Hopital Robert Debre, Paris, France
    Haematologica 92:1691-4. 2007
    ..4 years (range 0.5-7 years). Steroid therapy was stopped or tapered at 50-100% of the baseline dosage in all long-term responders. Moderate side effects and infection occurred only in 4 and 1 children respectively...
  12. ncbi request reprint [Outcome of children cured of acute lymphoblastic leukemia]
    Marie Dominique Tabone
    Hémato Oncologie Pédiatrique, Hopital Armand Trousseau, 26 avenue du Dr A Netter, 75012 Paris
    Bull Acad Natl Med 193:1519-28. 2009
    ..Secondary neoplasms are rare, but some are related to previous treatments. Currently, post-cure quality of life is a major concern when choosing the treatment strategy...
  13. doi request reprint Pearson syndrome in the neonatal period: two case reports and review of the literature
    Elena Maria Manea
    AP HP, Hopital Armand Trousseau, Department of Pediatric Hematology Oncology and Université Pierre et Marie Curie, Paris, France
    J Pediatr Hematol Oncol 31:947-51. 2009
    ..This article describes 2 cases with a severe neonatal onset of the disease. A review of the literature reveals the atypical presentation of the disease in the neonatal period, which is often overlooked and underdiagnosed...